Viewing Study NCT02106520


Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2026-02-25 @ 6:30 PM
Study NCT ID: NCT02106520
Status: TERMINATED
Last Update Posted: 2015-11-20
First Post: 2014-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Sponsor: Hospices Civils de Lyon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module